Evidence Hub

Antibody Based Electrochemical Sensor for Detection of the Full-Length Phosphorylated TDP-43 Protein Biomarker of Amyotrophic Lateral Sclerosis

William Wallace, Meagan Tabobondung, Josephine Esposto, S. Martic

Journal of the Electrochemical Society, 2023

3 citations

Abstract

Transactive response DNA binding protein (TDP-43) is a biomarker associated with neurodegenerative diseases, specifically amyotrophic lateral sclerosis (ALS). ALS remains without treatment or a cure, and diagnosis relies on the onset of symptoms. Hence, novel methods are needed for the early detection of TDP-43 as an ALS biomarker. Toward this aim, the detection of full-length phosphorylated TDP-43 (pTDP-43) was achieved by using the electrochemical impedance spectroscopy (EIS)-based biosensor. The TDP-43 antibodies (Abs) on gold (Au) surfaces (Ab-Au) were employed as recognition probes for the protein detection. EIS was used to characterize the Ab-Au surface before and after pTDP-43 binding. In the presence of a solution redox probe, [Fe(CN)6]3-/4-, the dramatic changes in the charge-transfer resistance (Rct) values were observed after the pTDP-43 binding and were directly related to the amount of protein present in solution. Sensitivity for pTDP-43 was highly dependent on the antibody used as a recognition probe, and the limit of detection was 11 ± 6 nM with a large dynamic range, and an excellent selectivity against the common protein. The electrochemical immunosensor may be easily extended for the detection of other degenerative disease biomarkers.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free